Results 211 to 220 of about 13,281 (220)
Some of the next articles are maybe not open access.

Related searches:

GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma.

New England Journal of Medicine, 2023
BACKGROUND Immunotherapy with chimeric antigen receptor (CAR)-expressing T cells that target the disialoganglioside GD2 expressed on tumor cells may be a therapeutic option for patients with high-risk neuroblastoma.
F. del Bufalo   +34 more
semanticscholar   +1 more source

Chemostratigraphy of the lower Cretaceous Mural Limestone, Rancho Bufalo section, Sonora, Mexico: Implications for OAE 1b

, 2021
J. Madhavaraju   +5 more
semanticscholar   +1 more source

Superovulatory response of river bufalo (Bubalus bubalis ).

Theriogenology, 1990
C. Karaivanov   +4 more
semanticscholar   +1 more source

GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/2 trial

Nature Medicine
F. Locatelli   +27 more
semanticscholar   +1 more source

Donor-derived GD2-specific CAR T cells in relapsed or refractory neuroblastoma

Nature Medicine
C. Quintarelli   +28 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy